Person: ARICI, MUSTAFA KEMAL
14 results
Search Results
Now showing 1 - 10 of 14
Publication Yag laser capsulotomy rates of 50 years and older individuals after use of the Zaraccom Ultraflex intraocular lenses(2012-01-01T00:00:00Z) TOKER, Mustafa Ilker; Ozec, Ayse Vural; DURSUN, Ayhan; YURDAKUL, Ismail; ERDOGAN, Haydar; TOPALKARA, Aysen; Arici, MUSTAFA KEMAL; ARICI, MUSTAFA KEMALAim: to evaluate the rate of symptomatic posterior capsule opacification requiring Nd:YAG capsulotomy in patients who underwent cataract extraction and implantation of zaraccom ultraflex lenses (one-piece hydrophobic acrylic square edged intraocular lens).Publication [The Investigation of Acanthamoeba and Other Free Living Amoeba in Swab Samples Obtained from Conjunctiva and Eye Lid].(2015-09-01T00:00:00Z) YÜNLÜ, Ö; ÖZÇELIK, SEMRA; Arıcı, MUSTAFA KEMAL; ÖZÇELİK, SEMRA; ARICI, MUSTAFA KEMALPublication Association of neutrophil/lymphocyte ratio and retinal vein occlusion(2015-07-01T00:00:00Z) DURSUN, AYHAN; ÖZTÜRK, SULTAN; YÜCEL, HASAN; Ozec, Ayse Vural; DURSUN, Feyza Gulac; TOKER, MUSTAFA İLKER; ERDOĞAN, HAYDAR; ARICI, MUSTAFA KEMAL; TOPALKARA, AYŞEN; ARICI, MUSTAFA KEMALPurpose: To evaluate the association between neutrophil/lymphocyte ratio (NLR) and the development of retinal vein occlusion (RVO).Publication Evaluation of inner and outer retinal thickness in patients receiving intravitreal ranibizumab injections for diabetic macular edema(2016-01-01T00:00:00Z) DURSUN, AYHAN; Ozec, Ayse Vural; Kirboga, Kadir; DURSUN, Feyza Gulac; TOKER, MUSTAFA İLKER; ERDOĞAN, HAYDAR; ARICI, MUSTAFA KEMAL; ARICI, MUSTAFA KEMALPurpose: To measure inner and outer retinal thickness with optical coherence tomography (OCT) in patients in whom intravitreal ranibizumab was administered due to diabetic macular edema (DME) and to investigate its relation to the visual prognosis.Publication Oftalmolojide Prizmalar(2017-03-01) UMURHAN AKKAN, JÜLİDE CANAN; ARICI, MUSTAFA KEMAL; UMURHAN AKKAN, JÜLİDE CANAN; ARICI, MUSTAFA KEMALPublication Total oxidative stress, paraoxonase and arylesterase levels at patients with pseudoexfoliation syndrome and pseudoexfoliative glaucoma(2015-10-01T00:00:00Z) Dursan, Feyza; Ozec, Ayse Vural; AYDIN, HÜSEYİN; TOPALKARA, AYŞEN; Darsun, Ayhan; TOKER, MUSTAFA İLKER; ERDOĞAN, HAYDAR; ARICI, MUSTAFA KEMAL; ARICI, MUSTAFA KEMALAIM: To investigate the oxidative stress status of the aqueous humor and serum of patients with pseudoexfoliation (PEX) syndrome and pseudoexfoliative glaucoma (PEG) and to measure paraoxonase (PON) and arylesterase (ARE) levels.Publication Relationship between mean platelet volume and central serous chorioretinopathy(2017-02-01T00:00:00Z) DURSUN, AYHAN; TOKER, MUSTAFA İLKER; Ozec, Ayse Vural; BOZALİ, ERMAN; Kirboga, Kadir; DURSUN, Feyza Gulac; ERDOĞAN, HAYDAR; TOPALKARA, AYŞEN; ARICI, MUSTAFA KEMAL; ARICI, MUSTAFA KEMALThe aim of this study was to investigate the mean platelet volume (MPV) of patients with central serous chorioretinopathy (CSCR). Thirty patients were included in the study. Thirty healthy volunteers were recruited as the control group. All patients and control subjects underwent complete ocular examination. Hemoglobin, hematocrit, white blood cell, neutrophil, lymphocyte, platelet count, and MPV of the participants were recorded. Data of patients with CSCR were compared with the control subjects. Patients with CSCR had significantly higher MPV values (9.76 +/- 1.36 fL) compared with the control subjects (8.37 +/- 0.72 fL) (p = 0.004). No significant difference was found in platelet counts between the CSCR group and the control group (259 +/- 53.75 and 243 +/- 52.11 K/Ul, p = 0.253). According to the receiver operator characteristics curve analysis, the optimal cut-off value of MPV to predict the CSCR was > 9.4, with 60.0 % sensitivity and 93.3 % specificity. Our results demonstrated that the MPV values were significantly higher in patients with CSCR. MPV may be used as a predictive tool for identifying risk for CSCR.Publication Comparison of the effects of bevacizumab and ranibizumab injection on corneal angiogenesis in an alkali burn induced model(2012-08-18T00:00:00Z) DURSUN, AYHAN; ARICI, MUSTAFA KEMAL; DURSUN, FEYZA; Ozec, Ayse Vural; TOKER, MUSTAFA İLKER; ERDOĞAN, HAYDAR; TOPALKARA, AYŞEN; ARICI, MUSTAFA KEMALAIM: To investigate the effects of bevacizumab and ranibizumab on corneal neovascularization in an alkali bum-induced model of corneal angiogenesis.Publication The Association between Diabetic Retinopathy and Levels of Ischemia-Modified Albumin, Total Thiol, Total Antioxidant Capacity, and Total Oxidative Stress in Serum and Aqueous Humor(2014-01-01T00:00:00Z) Kirboga, Kadir; ÖZEÇ, ABDULLAH İLKER; KOSKER, Mustafa; DURSUN, AYHAN; TOKER, MUSTAFA İLKER; AYDIN, HÜSEYİN; ERDOĞAN, HAYDAR; TOPALKARA, AYŞEN; ARICI, MUSTAFA KEMAL; ARICI, MUSTAFA KEMALPurpose. To investigate the oxidant and antioxidant status of patients with type 2 diabetes mellitus and nonproliferative diabetic retinopathy (DRP). Methods. Forty-four patients who had cataract surgery were enrolled in the study. We included 22 patients with DRP in one group and 22 patients in the control group. Samples of aqueous humor and serum were taken from all patients. Serum and aqueous ischemia-modified albumin (IMA), total thiol, total antioxidant capacity (TAC), and total oxidative stress (TOS) levels were compared in two groups. Results. Median serum IMA levels were 44.80 absorbance units in the DRP group and 40.15 absorbance units in the control group (P = 0.031). Median serum total thiol levels in the DRP group were significantly less than those in the control group (3051.13 and 3910.12, resp., P = 0.004). Mean TOS levels in the serum were 2.93 +/- 0.19 in the DRP group and 2.61 +/- 0.26 in the control group (P = 0.039). The differences in mean total thiol, TAC, and TOS levels in the aqueous humor and mean TAC levels in the serum were not statistically significant. Conclusion. IMA, total thiol, and TOS levels in the serum might be useful markers in monitoring the risk of DRP development.Publication Miltefosine and polyhexamethylene biguanide: a new drug combination for the treatment of Acanthamoeba keratitis(2014-03-01T00:00:00Z) POLAT, ZEHRA; WALOCHNIK, Julia; OBWALLER, Andreas; Vural, Ayse; DURSUN, AYHAN; ARICI, MUSTAFA KEMAL; ARICI, MUSTAFA KEMALBackgroundIn this study, a series of compounds - miltefosine, polyhexamethylene biguanide, chlorhexidine and propamidine isethionate - and combinations of the latter three agents with miltefosine were prepared and used in a rat model for the topical treatment of Acanthamoeba keratitis.